chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 days after vaccination developed GI symptoms.  She was seen in  ER on 2/22 for abd pain, vomiting & diarrhea & 2/27 for vomiting. Mom reports approx 3 weeks of ongoing symptoms.  Child started with a few episodes of vomiting in a day then would go a couple of days without vomiting. And the cycle would restart. She also had diarrhea. Last episode of vomiting was 2/24 & last episode of diarrhea was 2/25 am. Denies further abd pain. Since then acting well.  She had labs the second time and white count was elevated at 13,600 but the concerning thing was that there were 62% lymphocytes but also some early appearing cells with at least 1 cell that appeared to be a blast versus a reactive lymphocyte.  Continued below.  Approximately 10% of the lymphocytic cells were what he described as lymphoplasmacytic type cells that are usually seen in older adults but could be a reactive component to an infectious process on the CBC according to pathologist and he sent it out for consult who agreed.  Concern was for early leukemia or malignancy.  We repeated the CBC twice subsequently and the number of lyphoplasmacytic cells declined and WBC normalized and Hemoglobin and platelets were normal.  It is unclear whether this was a reaction to the vaccine or an infectious process but mother strongly believes it was a reaction to the vaccine so I said I would report it.  I checked her today and exam was normal.  We are waiting for the patholigst to review the CBC but it appears normal to me.
Redness is getting bigger; Warm to the touch Injection Site; White spot near injection site; Swollen Injection Site; Red Injection Site (Around the Arm up to near elbow); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site), CONDITION AGGRAVATED (Redness is getting bigger), VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)) and VACCINATION SITE SWELLING (Swollen Injection Site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 032H20A) for COVID-19 vaccination.     No Medical history was provided by reporter.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site) and VACCINATION SITE SWELLING (Swollen Injection Site). On 20-Feb-2021, the patient experienced CONDITION AGGRAVATED (Redness is getting bigger). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site), CONDITION AGGRAVATED (Redness is getting bigger), VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)) and VACCINATION SITE SWELLING (Swollen Injection Site) had not resolved.            No relevant concomitant medications were reported  Treatment details included cetirizine, antibiotics (has not taken yet), and ice pack.
Initial report received from a healthcare professional on 06 January 2014. A 44-year-old patient had received a first dose of FLUZONE QIV (lot number: not reported, route of administration was not reported) in the left deltoid on 15 December 2013. The patient had a medical history of asthma and gluten allergy and the patient had received a flu vaccine in June (year not reported), and had no reaction. On 15 December 2013, few hours after vaccination, the patient became hot and red, had vomiting for several days, nausea, trouble breathing, shortness of breath, knees swelled up and had trouble walking and shaking, chest pain. The patient had similar episode which were unrelated to a vaccine in the past but the past time became blind briefly and the patient had to take prednisone which was diagnosed as allergic reaction. Laboratory investigation and corrective treatments were not reported. The patient had not recovered till the time of this report. Documents held by sender: none.
Urticaria. Rash. Prelone 5mg/5ml- Diphenhydramine 12.mg/5ml. Hydrocortisone 1% ointment TID.
Third in series, caused full body flushing, diaphoresis, vertigo, full arm vasoconstriction, 6-8cm tissue "puckering" at injection site which later sloughed off/scaled for about 2-3 mos.
Tinnitus in both ears on day of vaccination that did not subside. PCP prescribed corticosteroids, which did not  help. Was referred to ENT.
Beginning two days after the vaccine, I began experiencing total body shudders/spasms. At first it was only in the legs and/or arms intermittently and then eventually my entire body.  Each shudder/spasm lasted no more than one second, but when my entire body started spasm it, it almost seemed like a mini seizure.  Over the next few weeks, the shudders/spasms began to subside.  I no longer have full body spasms, but I still do have intermittent leg and arm spasms.  They are much less than they were previously, but they are still happening.  I never experienced such shudders/spasms prior to vaccination.  Also, starting two days after the vaccine, my chest began to hurt.  Throughout the course of the day, I would feel either a heavy pressure or sharp, low intensity pain.  I am still experiencing these sensations intermittently.  I never had such sensations/pain before vaccination.
I have psoriasis and take a biological called skyrizi to control outbreaks. It has been very effective for me. A few days after the second shot I noticed that I began to have a flare up .  It has been 3 weeks since the shot and the flare up which is on the bottom of my feet is much worse than it has ever been.  I have an appointment with the dermatologist but it is in June so I plan to call and see if she has had anyone else have an immune response like this.
pt exp pain in lt upper arm, lasting longer than 48hr p/vax;pt devel lt axillary lymphadenopathy;pt recovered @ the date of this report;this is 1 of 4 pt to devel an inj site rxn p/vax;
Mother called stating child started cougning when playing and jumping. Was concerned that this might be a reaction to H1N1 vaccine.  Child has asthma.  Mother states this cough is different than asthmatic cough.  This cough is more like type of cough child has when she is getting a cold.  No other symptoms reported other than cough.  Questioned as to whether there were any congestion, fever, rashes, itching or upset stomach.  Denied all but cough.
About two weeks after receiving the vaccine, I have developed a mild, but persistent dry cough and uncomfortable sensation in my lungs.  It feels as if there is a foreign body in my lungs that needs to be expelled.  Please note;  I am extremely healthy for my age (now 67).  I do not have a history of allergies or somatic complaints, but I do have a history of a number of hospitalizations for pneumonia.  I recently moved and will be seeing a new doctor on June 2nd.  I understand that the symptoms I am reporting may have no relationship to the vaccine, however, I do hope it will be entered into your data base and that there will be an opportunity to provide follow-up in case there  are an increased number of reports that are similar.
Pt recvd vax  in 1986 & did well approx 3 yrs & 1JAN90 noted to have a viral illness w/persistently elevated SGOT & SGPT, serum bilirubin & alkaline phosphatase were nl; beginning 1991 pt devel chronic fatigue w/weakness, arthralgia & h/a;
pt recvd vax 29DEC92 & 15FEB93 exp unspecified react; No further details were provided;
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 18-AUG-2017, the patient was vaccinated with VARIVAX (lot # N002204, expiration date 19-JAN-2019) (route, dosage and frequency were not reported) which was improperly stored. The sterile diluent used to reconstitute the VARIVAX was properly stored. No symptoms reported. The vaccine was stored at -1.6 degree centigrade for 15 hours. The vaccine had previous temperature excursion which was stored at a temperature from -9 degree centigrade to 8 degree centigrade for 30 hours and 15 minutes. Data logger was involved. No further information was provided. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010758: US-009507513-1708USA010756: US-009507513-1708USA010754: US-009507513-1708USA010762: US-009507513-1708USA010759: US-009507513-1708USA010760: US-009507513-1708USA010761.
Mild chills; fatigue; Mild tenderness in the armpit of my left arm.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome. The patient did not have any allergies to medications, food, or other products. Concomitant medications included vitamin d nos, fish oil and multi vitamins; al from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 for COVID-19 immunisation (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 09:00, the patient experienced mild chills, fatigue and mild tenderness in the armpit of left arm. The patient did not receive any treatment for the events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event's mild chills, fatigue and mild tenderness in the armpit of left arm were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
he started experiencing trigger thumb again; extreme fatigue; sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), TRIGGER FINGER (he started experiencing trigger thumb again) and FATIGUE (extreme fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A, 030A21A, 017F21A and 042J21A) for COVID-19 prophylaxis.     Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Shingrix vaccine on 07-Apr-2023. Past adverse reactions to the above products included No adverse event with Shingrix vaccine. Concurrent medical conditions included Hypertension (well controlled with medication), Lipids abnormal and Allergy to antibiotic (Erythromycin).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), TRIGGER FINGER (he started experiencing trigger thumb again) and FATIGUE (extreme fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (extreme fatigue) had resolved and TRIGGER FINGER (he started experiencing trigger thumb again) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2023-720918 (Patient Link).   Reporter did not allow further contact
severe muscle pain; headaches; Fever; Utter exhaustion; This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced muscle pain, headache, fever and exhaustion. On an unknown date, the outcome of the muscle pain, headache, fever and exhaustion were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, headache, fever and exhaustion to be related to Shingrix.  Additional details were provided are as follows: The age at vaccination not reported. The patient received 1st dose of Shingrix 11 days ago of reporting date and still patient had severe muscle pain, headaches, fever and utter exhaustion. The reporter asked that was this normal.
About 4 hours after the shot, his cheeks got super red (I initially ignored it because I just assumed he was getting a fever post vaccine). At the 6-hour mark, the redness turned to hives, and he started with a little cough. I did not give him anything because I wanted to see what happened. By the 8-hour mark, the hives were stable, but his cough was getting worse. I started his inhaler to try to avoid an ER trip. At the 12-hour mark, the hives went back to just redness. At the 14-hour mark, the redness of his cheeks disappeared. I had to do his albuterol q4 until Wednesday morning then I was able to back off and stop it. I notified his pediatrician who advised that he no longer get COVID vaccines since he also reacted to his first one (VAERS report filed for that one previously).
Pfizer-BioNTech COVID-19 Vaccine EUA Within 24 hours after having the vaccine both feet were swelled up.  Some of the swelling went down during the night but came back the following day.  The swelling continued without any improvement and I started wearing compression socks on the 5th. day. (3-18)  I should have started sooner but I was hoping the swelling would go away on its home.  I have had some minor swelling in both feet at various times in the past 3 months due to some minor sprains and also because of limited movement due to my back injury.  The compression socks help keep the swelling down and I do not know how long I will need to use them.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information provided about the patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies. On 23-MAY-2017 (also reported as "05/23/2018"), the patient received an expired injectable dose of VARIVAX (lot # L017145 with expiration date on 13-MAY-2017) for prophylaxis (strength, dose, frequency, route of administration and anatomical location were not reported). No adverse effects were reported. Additional information has been requested.
I developed a migraine withing a few hours of getting the vaccine.  This has been waxing and waning since that day, but not gone away.  Saw Doctor on 10/10/22.  Doctor noticed that vaccine was Moderna and previous versions had been Pfizer.  Doctor just took blood pressure and temperature.  Prescribed etodolac 400 mg and Acetaminop hencod 3 for pain.
patient states she had a fever and chills and then an abdominal rash. she called md
Felt exhausted and ill first 4 days after vaccine , first day after being the worst,.then better as days went on.  13 days after vaccine itchy rash left should top to mid back.. left arm rash , swelling, painful as if bruised, rash on right buttock itchy.. left forearm ..face left side near mouth.. next day by right side.. left ear in back of ear  2 days later right ear.. used cortizone cream, benadryl creme .. helping.. took benedryl pill (1) every 4 hours on day 2 by day 4 all cleared.
Patient received his first dose of the Pfizer-BioNTech COVID-19 vaccine on 12/28/2020 without and adverse events reported after this dose. However, after receiving his second dose of the vaccine on 1/15/2021 in his left deltoid, he noted a rash on his bilateral antecubital fossae on the morning of 1/21/2021. He reported that the rash was erythematous in nature, raised, and pruritic describing the presence of small papules over an erythematous patch of skin that was approximately 1 inch in diameter on both sides. He noted the rash on both antecubital fossae at the same time on the morning of 1/21/2021. Since onset, he has been using topical hydrocortisone cream for symptomatic management. Although these lesions have improved, they have not yet completely resolved. He denied any other symptoms associated with the rash and also denied any other exposures or changes in skin products that might have precipitated this rash.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypotension-Medium, Systemic: Shakiness-Mild, Additional Details: Patient came in for 2nd dose of pfizer vaccine on 6/9/21. He complained he was feeling dizzy after the shot,checked his blood pressure and ot was 90/45. Gave him a bottle of water, rechecked his blood pressure and it was 80/40. He asked if we can call 911, paramedic showed up in less than 5 min, no epinephrine was given to the patient. Paramedic said everything looks fine, he had a syncopy after the shot. His final blood pressure was 130/90. He was escortrd out,willl follow up with him on 6/9/21.
Two days after receiving my second dose my taste buds completely changed.  Foods that I routinely ate before the shot I can no longer eat because of the way they now taste. The taste mimics the taste of feces.
Patient received dose 1 of the Pfizer COVID vaccine (lot FK5127) at approximately 1600. At 1607, patient reported feeling sweaty and hearing "raining" in his ears. PHN and PHN approached noting patient appeared pale. Vital signs: O2 99%, blood pressure 90/62, respirations 20, pulse 94. Patient's mother reported patient had no allergies, took no medication, and no current medical conditions but was hospitalized at age 2 due to pneumonia. PHN offered Benadryl but the patient's mother declined. PHN educated on remaining for 30min monitoring from time of symptom report, to follow up with provider, and ER precautions. Patient's mother reported the patient had eaten prior to arrival and the patient was anxious about needles. Mother reported that after the flu shot in 2020 the patient felt lightheaded but no other similar reaction. At 1620, patient reported symptoms had improved. PHN noted patient's color had returned. Vital signs: O2 99%, pulse 88, blood pressure 82/40, respirations 20. At 1640, vital signs: blood pressure 84/40, O2 98%, pulse 78, respirations 20. Patient stood up slowly, monitored by PHN. At 1644, patient left walking with steady gait accompanied by mother.
Several patches of rash, minor itchiness. No pain. Resembled shingles.
Fever, chills, bed-ridden for several days starting the night after vaccination (second dose).
Client became light headed and clammy.  Responsive to verbal and tactile stimulation.  No loss of consciousness.  Alert, aware and responsive.  Skin noted to be moist and clammy to touch.  Pale complexion.  Dad was present during event and stated client was recovering from COVID-19, had his last neg. test obtained on 5/14/21.  Dad did not want 911 services activated, however, he stated and nursing also advised that he take client to see his PCP.  When exit, client was alert, verbal and ambulatory; no sign of acute distress.  Exit at 3:47pm.
Patient presented to the ED and was subsequently hospitalized for COVID-19 within 6 weeks of receiving COVID vaccination. He was in intensive care with pneumonia and severe sepsis.
DIZZY to the extent walking was hard to start with for 2 days. very gradually went away over the next 10 days. tue 3/3 was first day not dizzy when turning when cooking.
ADMINISTRATION ISSUES:  The vial was previously punctured on 11/30/2021.  The patient does not have any side effects. The patient was informed and will re-vaccinate with the pediatric Pfizer dosage as soon as possible.
stomach spasms, which have been diagnosed as abdominal myoclonus.  has led to spasms in back, legs, face.  Is on klonzapen daily, cymbalta.  was on other medications but have since been taken off them.  had to sit out semester of college. 8/14/08-records received for DOS 12/14-12/16/07-DC DX: Gastroenteritis now improved. Developed nausea, vomiting, diarrhea and abdominal crampy pains, presented to ED.  1/25/2010 Follow up: Diagnosed with "myclonus". Takes 7-8 medications daily, maybe for life.
INJECTION SITE VESICLES; INJECTION SITE ERYTHEMA; INJECTIONSITE RASH; INJECTION SITE SWELLING  Information has been received from a physician concerning a 4 year old female who on 07-OCT-2006 was vaccinated with a 0.5 ml dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wister RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (Lot# 654041/0662F). On 08-OCT-2006 the patient experienced redness and swelling at the injection site and bumps and blisters.  It was reported that one of her blisters burst and her younger sister experienced bumps from possible transmission (WAES # 0612USA01410).  Unspecified medical attention was sought.  No product quality complaint was involved.
pt recv vax; exp flu-like sx following vax; in f/u ,MD stated that she did not have a pt who exp an adverse rxn;
Child received Meningococcal (MCV4) IM in deltoid instead of HPV9 vaccine. Mother of child stated that child has no adverse reaction.
muscle pain at injection site; decrease in mobility / hard to reach for things; This case was reported by a pharmacist via call center representative and described the occurrence of injection site muscle pain in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number P100105209 ?, expiry date 9th June 2020) for prophylaxis.   On 28th October 2019, the patient received the 1st dose of Shingrix. On 29th October 2019, 1 days after receiving Shingrix, the patient experienced injection site muscle pain and injected limb mobility decreased. On an unknown date, the outcome of the injection site muscle pain and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the injection site muscle pain and injected limb mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The reporter stated that the patient after vaccination had muscle pain at injection site and decrease in mobilityand it was hard to reach for things. The patient missed 1 day of work, due to severe pain. The patient provider she remembers hearing a popping noise during administration. The patient had seen her provider twice since the administration date and had received dose 2 from another provider on 28th December 2019.
Patient received both doses of Pfizer, then a dose of Janssen, the the Pfizer booster. He claims it was per his doctor's recommendation.